Citi Downgrades Unity Biotechnology Inc (UBX) to Neutral
Tweet
Share
E-mailGet Alerts UBX Hot Sheet
Price: $0.20 --0%
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz downgraded Unity Biotechnology Inc (NASDAQ: UBX) from Buy to Neutral with a price target of $5.00 (from $31.00).
For an analyst ratings summary and ratings history on Unity Biotechnology Inc click here. For more ratings news on Unity Biotechnology Inc click here.
Shares of Unity Biotechnology Inc closed at $12.43 yesterday.
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
- Semiconductor Manufacturing International Corp. (981:HK) (SMI) PT Raised to HK$153 at Goldman Sachs
- Harley-Davidson (HOG) PT Raised to $33 at DA Davidson Amid Progress on Back to Bricks Strategy
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
